Hepatitis B Core Antibody Positive: What Does It Mean?

A positive hepatitis B core antibody test, also written anti-HBc positive, means your body has met the hepatitis B virus at some time. CDC describes total core antibody as developing in all hepatitis B infections, resolved or current, and usually lasting for life. On its own it cannot tell whether the infection is past or ongoing, so it is always read together with the hepatitis B surface antigen (HBsAg) and surface antibody (anti-HBs).

This guide is for adults who already have a hepatitis B result. It explains the common result patterns and the usual next questions. It cannot tell you which pattern applies to you or what treatment, if any, you need.

Most people with a positive core antibody feel well. Get medical advice the same day if you develop yellowing of the skin or the whites of the eyes (jaundice), dark urine, pale stools, ongoing vomiting or new pain in the upper abdomen. NHS notes that jaundice may be harder to see on brown or black skin, so check the whites of the eyes.

Seek emergency care if jaundice comes with confusion, unusual drowsiness or a rapidly swelling abdomen, or if you feel severely unwell. Cleveland Clinic lists acute liver failure as a complication of hepatitis B and notes that it can develop very quickly. If you are receiving chemotherapy or other immune-suppressing treatment, report any of these signs to your treating team straight away.

Hepatitis B testing is usually done as a panel. Look for all three results on your report, and check whether the core antibody was 'total' or 'IgM'. CDC explains that IgM core antibody points to a recent infection, generally within about six months, while total core antibody can reflect an infection from any time in the past.

Common patterns, based on CDC's interpretation table, include:

• Core antibody positive, surface antigen negative, surface antibody positive: usually a resolved past infection with immunity.
• Core antibody positive, surface antigen negative, surface antibody negative: an 'isolated core antibody' result, which has several possible explanations (see below).
• Core antibody positive and surface antigen positive: hepatitis B is currently present. This pattern needs medical assessment to work out whether the infection is acute or chronic.
• Core antibody negative and surface antibody positive: usually immunity from a completed vaccination course, not infection.

An isolated core antibody means only the core antibody is positive. CDC lists several possible explanations: a past infection where the surface antibody has faded over time; an occult infection, where surface antigen is negative but virus DNA is still detectable; a surface antigen variant that the laboratory test does not pick up; a false positive; or, in an infant, antibody passed from the birth parent.

Because these explanations lead to different next steps, the result is often checked further. CDC guidance from 2023 says that repeat testing with the same assay is warranted when a person has no risk factors, and that a hepatitis B DNA (viral load) test can look for occult infection. If the core antibody turns out to be a false positive, CDC says the person is considered susceptible and should be offered hepatitis B vaccination.

A core antibody does not by itself show that you can pass hepatitis B on. CDC links infectiousness to the presence of surface antigen. When surface antigen is negative and surface antibody is positive, the pattern usually reflects a cleared infection. With an isolated core antibody, ask whether a hepatitis B DNA test is needed before assuming there is no risk to others.

Hepatitis B spreads through blood and certain body fluids, for example through sex without a condom, shared needles, or unsterilised equipment, according to NHS. If you are unsure about precautions for partners or household members, or about vaccinating them, ask your clinician rather than guessing.

A past hepatitis B infection can come back, or reactivate, when the immune system is suppressed. CDC advises that people with resolved infection be counselled about this risk, and notes that the highest-risk treatments include B-cell depleting medicines. CDC refers more broadly to immunosuppressive and cytotoxic treatment, which includes many forms of chemotherapy, and Cleveland Clinic lists immunosuppressant medicines as a cause of reactivation.

CDC also notes that antiviral medicine started before immune-suppressing or cytotoxic treatment may help prevent reactivation. Whether you need preventive medicine or regular monitoring depends on the treatment planned and your full results, and is decided by your clinicians. Do not stop or delay a planned treatment yourself; make sure the prescribing team and a liver or infectious disease specialist both know your result.

Bring the full report with all three hepatitis B results and the test date. These questions can help:

• Was my core antibody total or IgM, and what were my surface antigen and surface antibody results?
• Does this pattern mean a past infection, a current infection, or is it still unclear?
• If only the core antibody is positive, should it be repeated, or should I have a hepatitis B DNA test?
• Do I need liver blood tests or a referral to a liver specialist?
• I am starting chemotherapy or an immune-suppressing medicine. How will reactivation be prevented or monitored, and who is responsible?
• Should my partner or household members be tested or vaccinated? Would I benefit from vaccination?

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a positive core antibody described their result pattern and follow-up, such as a repeat test, a DNA test or a referral before cancer treatment, can help you spot questions you had not thought to ask. Another person's results cannot explain yours or tell you whether you have an infection. Use what you read to prepare questions for your own clinician, and see our guide on comparing a similar case with your own.

Hepatitis B and hepatitis C are different viruses with different tests. A positive hepatitis C antibody is followed by an RNA test, which is covered in our separate guide on a positive hepatitis C antibody test. For hepatitis B, keep the core antibody, surface antigen and surface antibody results together, note the date of each, and ask who will arrange any follow-up so the result is not lost before future treatment.